For adults with systemic lupus erythematosus (SLE) and cutaneous disease, what are the effects of intravenous (IV)/subcutaneous (SC) monoclonal antibodies?
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
1989 ◽
Vol 83
(3)
◽
pp. 1002-1009
◽
Keyword(s):
1983 ◽
Vol 80
(3)
◽
pp. 850-854
◽